HEMOGLOBINOPATHY
Clinical trials for HEMOGLOBINOPATHY explained in plain language.
Never miss a new study
Get alerted when new HEMOGLOBINOPATHY trials appear
Sign up with your email to follow new studies for HEMOGLOBINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
15-Year watch begins for pioneering sickle cell 'Cure' patients
Disease control Recruiting nowThis study will follow patients for 15 years after they received an experimental gene-editing treatment (BEAM-101) for sickle cell disease or similar blood disorders. The main goal is to monitor their long-term health and safety, and see how well the treatment continues to work o…
Matched conditions: HEMOGLOBINOPATHY
Sponsor: Beam Therapeutics Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Scientists track blood cell 'Expiration Dates' to unlock clues for sickle cell cure
Knowledge-focused Recruiting nowThis study aims to understand how long red blood cells survive in people with sickle cell disease, thalassemia, and other inherited blood disorders. Researchers will label a small sample of a participant's own blood cells with a safe vitamin (biotin) and track them over several m…
Matched conditions: HEMOGLOBINOPATHY
Phase: EARLY_PHASE1 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:19 UTC